Benign prostatic hyperplasia Urological and Genital Diseases Prostatic hyperplasia
Conditions
Interventions
All patients will have the following investigations at the recruitment visit: prostate specific antigen (PSA), peak urinary flow rate, post-voiding urine volume, ultrasound for the prostate, kidneys a
Sponsors
The Continuous Medical Research Centre at King Khaled University Hospital (Saudi Arabia)
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Male patients; no specific age group but for the condition most patients will be aged 50 years and older 2. Naive patients with BPH 3. Have an International Prostate Symptom Score (IPSS) more than seven 4. Must be living in Riyadh city; patients from the peripheries will be excluded 5. Patients who are already on alpha blockers can be included after a washout period of two weeks
Exclusion criteria
Exclusion criteria: 1. Patients with renal failure 2. Acute angle glaucoma 3. Arrythmias (will be excluded by the past medical history and the current cardiac medication)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptoms measured by: 1. The International Prostatic Symptoms Score (IPSS) 2. Peak urinary flow rate (Q max) All outcomes will be assessed at visit one (zero time), visit two (eight weeks), visit three (one week from the last visit for wash out) and visit four (final visit at sixteen weeks). | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Post voiding urine volume (PVR) 2. Ultrasound (optional) All outcomes will be assessed at visit one (zero time), visit two (eight weeks), visit three (one week from the last visit for wash out) and visit four (final visit at sixteen weeks). | — |
Countries
Saudi Arabia
Outcome results
None listed